Summary Targeted overexpression of the c-myc oncogene induces neoplastic transformation in immortalized, non-tumorigenic mouse mammary epithelial cells (MMEC). Experiments in the present study were conducted to examine whether cellular transformation induced by c-myc oncogene is associated with altered metabolism of 17,-oestradiol (E2). The Keywords: c-myc expression; oestradiol metabolism; mammary carcinogenesis It is well recognized that oestrogens exert a profound influence on mammary epithelial cell growth, differentiation and neoplastic transformation Prudhomme et al, 1984; Mauvais-Jarvis et al, 1986; Siiteri et al, 1986) . The molecular and biochemical mechanisms important for oestrogen responsiveness and the influence of altered oestrogen responsiveness on mammary cell carcinogenesis, however, are not fully understood. Our earlier studies on immortalized, non-tumorigenic mouse mammary epithelial cell lines have shown that transfection of the cell line with myc or Ras oncogenes results in neoplastic transformation. Before tumorigenesis in vivo, myc as well as Ras transfectants exhibit aberrant hyperproliferation in vitro (Telang et al, 1990 (Telang et al, , 1991 Suto et al, 1992) . Thus, persistent oncogene expression and aberrant hyperproliferation may represent molecular and cellular biomarkers for neoplastic transformation.
It is well recognized that oestrogens exert a profound influence on mammary epithelial cell growth, differentiation and neoplastic transformation Prudhomme et al, 1984; Mauvais-Jarvis et al, 1986; Siiteri et al, 1986) . The molecular and biochemical mechanisms important for oestrogen responsiveness and the influence of altered oestrogen responsiveness on mammary cell carcinogenesis, however, are not fully understood. Our earlier studies on immortalized, non-tumorigenic mouse mammary epithelial cell lines have shown that transfection of the cell line with myc or Ras oncogenes results in neoplastic transformation. Before tumorigenesis in vivo, myc as well as Ras transfectants exhibit aberrant hyperproliferation in vitro (Telang et al, 1990 (Telang et al, , 1991 Suto et al, 1992) . Thus, persistent oncogene expression and aberrant hyperproliferation may represent molecular and cellular biomarkers for neoplastic transformation.
The conventionally recognized markers for oestrogen responsiveness include (1) functional activity of oestrogen receptor as determined by receptor-ligand binding; (2) modulation of transcriptional activity, growth and induction of progesterone receptor (Prudhomme et al, 1984; Mauvais-Jarvis et al, 1986; Siiteri et al, 1986; Dubik and Shiu, 1992) ; (3) reversible suppression of growth by hormone antagonists (Clark et al, 1977; Mauvais-Jarvis et al, 1986; Siiteri et al, 1986; Dubik and Shiu, 1992) . Our recent studies on Ras-initiated MMEC/pHO6T cells as well as on Ras-transformed Tl/Prl cells have shown that the oncogene-initiated and tumorigenically transformed cells are responsive to E2, as also shown by their ability to metabolize the hormone and by reversible growth inhibition upon treatment with the non-steroidal antioestrogen tamoxifen (Telang et al, 1991; Suto et al, 1992) .
Mammary epithelial cells initiated independently with chemical carcinogen 7,12-dimethylbenz(a) anthracene (DMBA) and Ras oncogene exhibit elevated oestrogen metabolism via the formation of C16a-hydroxylated metabolites (Telang et al, 1991 Suto et al, 1993) . In addition, it has been proposed that the oestrogenmediated stimulation of growth of breast tumour-derived MCF7 cells may involve transactivation in the c-mvc promoter region (Dubik and Shiu, 1992 (Telang et al, 1990) . Routinely, MMEC and MMEC/mvc3 cells were maintained in DME/F12 medium supplemented with heat-inactivated 10% fetal bovine serum, 4 mM L-glutamine and 5 jg ml-' insulin. The stock MMEC/mvc3 cells were maintained in the presence of 400 jg ml-' G-4 18 to eliminate the accumulation of spontaneous revertants. For the experiments measuring the cellular metabolism of E,, the parental MMEC and the mvc transfectant MMEC/mvc3 cells were cultured in the absence of G-418 for 72 h to exclude the possibility of interference of the antibiotic with E, metabolism.
Growth characteristics
The growth pattern of MMEC and MMEC/myc3 cells was determined by a trypan blue exclusion test and haemocytometer counts for viability and growth. In addition, population doubling time (PDT), anchorage-independent growth (AIG) and mammary fat pad tumorigenicity assays were performed according to the published procedures (Ganguly et al, 1982; Telang et al, 1979 Telang et al, , 1990 Telang et al, , 1991 (Telang et al, 1990 (Telang et al, , 1991 . A [32P]-labelled, nick-translated 1.8 kb Sacl fragment of human c-mvc spanning the second exon was used as the probe. The blots were scanned and the hybridization signal was quantified by arbitrary scanning units (ASU) normalized to 20 ,ug of RNA loaded. The oestrogen receptor content of MMEC and MMEC/mvc3 cells was determined by the ligand binding assay (Castagnetta et al, 1992) and was expressed as fmol of oestrogen receptor protein (ERP) per 10 ,tg of DNA.
HPLC analysis of 17P-HSD activity
The relative extent of 1 7f-HSD activity was determined by measuring the interconversion of E, and El in the two cell lines.
T-25 flasks containing approximately 1.0x 106 MMEC and MMEC/mvc3 cells were incubated for 24 h in serum-free, phenol red-free and G-418-free medium in the presence of 2,tCi ml-'
[6,7-3H(N)]E, (specific activity 42.3 Ci mmol-', final concentration 4.6 x 10-8 M) or 2 ,tCi ml [6,7-3H(N)]E, (specific activity 41.9 Ci mmol-', final concentration 4.8 x 10-xM). The incubation medium was collected, and 1-ml aliquots were extracted with 9:1 ethyl-ether:acetone. The extracts were analysed by reverse-phase HPLC (C 18 column, 4.6 i.d. x 250 mm) under isocratic conditions (acetonitrile: 0.05 M citric acid, 40:60) at a flow rate of 1 ml min-' using a computer-aided optimized mobile phase (D'Agostino et al, 1985; Castagnetta et al, 1986) . The detection of E, metabolites was carried out using a UV detector and a three-channel radiometric detector, both on-line to HPLC as described previously British Journal of Cancer (1998) (Castagnetta et al, 1986 (Castagnetta et al, , 1991 . The cells were lysed in 0.1% sodium dodecyl sulphate (SDS), and DNA content was determined (Carruba et al, 1994) . The resulting data were normalized for total radioactivity and expressed as pmol 10 ,g-I cellular DNA or fmol ml-' after correction for equal cell numbers. Separate experiments were carried out to inspect the time and dose dependence of oestrogen metabolism in both MMEC and MMEC/myc3 cells. To this end, 5 x 105 cells were incubated in the presence of 1 nM tritiated E, for 3, 6, 12, 24, 48 and 72 h or exposed to increasing concentrations (0.1, 1, 10 and 100 nM) of Oestrone concentration (nM) (Telang et al, 1991 Suto et al, 1992 Suto et al, , 1993 (Fishman and Martucci, 1980; Fishman et al, , 1995 Telang et al, 1991 Suto et al, 1992 Suto et al, , 1993 Telang, 1996 G-418, lacked the expression of exogenous myc-specific 2.8 kb RNA transcript, exhibited a population doubling time of 24.3 ± 0.5 h, lacked anchorage-independent growth in vitro and lacked the ability to form tumours when transplanted into syngeneic recipients. These cells, however, exhibited a persistent ability for ductal morphogenesis at the transplant site (data not shown). In contrast, the MMEC/myc3 cell line did not exhibit any G-418 cytotoxicity, expressed the exogenous 2.8 kb transcript (15.0 ± 2.6 ASU 20,g-I RNA) and showed a shorter population doubling time of 18.3 ± 0.1 h (d.f. 5, t = 3.40, P = 0.01). Furthermore, MMEC/myc3 cells also showed a 132-fold increase in AIG relative to that observed in MMEC and were highly tumorigenic, exhibiting a 90% tumour incidence at 12 weeks after transplantation (data not shown). These results essentially confirm our earlier report (Telang et al, 1990) , suggesting that the expression of activated c-myc confers neoplastic transformation to mammary epithelial cells. In addition to overexpression of exogenous c-myc, the MMEC/myc3 cells exhibited a substantial reduction in oestrogen receptor levels. Thus, whereas the oestrogen receptor content of parental MMEC was 12.5 ± 3.9 fmol 10 ,ug-' DNA, it was decreased to 5.7 ± 1.7 fmol 10 jg-I DNA (d.f. 5, Table 2 that the reductive pathway of E, to E2 dominates over the opposing oxidative pathway of E2 to E, conversion, the reductive reaction being about 14-fold and 12-fold greater than the oxidative conversion in MMEC and MMEC/myc3 cells respectively. However, in MMEC/myc3 cells, both reductive and oxidative reactions are found to be significantly reduced, being about 32% (d.f. 11, t = 4.16, P = 0.0028) and 12% (d.f. 10, t = 3.40, P= 0.05) lower relative to those observed in MMEC cells.
Typical HPLC profiles of oestrogen metabolism in MMEC and MMEC/myc3 cells are illustrated in Figure 1 .
Time course experiments (3-72 h) were specifically designed to compare E, conversion to E2 in parental MMEC and c-myc-transfected cells. As shown in Figure 2 , the extent of the reductive pathway of 17j-HSD is significantly reduced (from three-up to 4.5-fold) in MMEC/myc3 cells. It is of interest that maximum E2
formation in the latter cell line was observed at 24 h (15.3%) or 48 h (20.4%), whereas it was steadily increasing with time in MMEC cells. Consistency in DNA values and cell counts was ensured for reproducibility of data. Parallel experiments carried out on MMEC and MMEC/myc3 cells using increasing precursor concentrations (from 0.1 up to 100 nM) showed that the proportion of E, formed remained relatively unchanged using either 1, 10 or 100 nm E, in both MMEC (33-35%) and MMEC/myc3 cells (8-10%), whereas it was remarkably greater (46% in MMEC cells and 17% in MMEC/myc3 cells) at the lowest E, concentration (0.1 nM) used (see Figure 3) .
Nevertheless, the extent of E2 formation was again significantly (from 2.6-up to 4.6-fold) lower in MMEC/myc3 cells with respect to the parental MMEC cells.
E2 hydroxylation in MMEC and MMEC/myc3 cells
The oestrogen metabolism was compared by radiometric determination of the relative extent of E2 conversion via the C2-and Cl16a-hydroxylation pathways (Table 3 ). The two cell lines exhibited persistent metabolic competence to convert E2. In parental MMEC cells, the extent of conversion of [C2-3H]E2 and of [C16x-3H]EB was 0.32 ± 0.04% and 0.14 ± 0.02% (per 104 cells) respectively (mean + s.d., n = 12). In MMEC/myc3 cells, the extent of conversion of [C2-3H]E2 was decreased to 0.16 ± 0.02%, while that of [Cl6ot-3H]E2 was increased to 0.37 ± 0.05%. To maintain consistency with the data from the experiments on interconversion of E2 and E,, the data from E2 metabolism are expressed as amounts of 2-OHE, and 16a-OHE, formed. The data presented in Table 3 demonstrate clearly that MMEC/myc3 cells exhibit about a 164.5% increase (d.f. 11, t = 5.25, P = 0.001) in 16ax-OHE, formation, with a concomitant 48.3% decrease (d.f. 11, t = 4.23, P = 0.001) in 2-OHE, formation. This results in a fourfold increase in the C16ax/C2 hydroxylation ratio.
DISCUSSION
Altered endocrine status of the mammary tissue plays an important role in the expression of tumorigenic phenotype (Telang et al, 1979; Ganguly et al, 1982; McCormick et al, 1982; MauvaisJarvis et al, 1986; Siiteri et al, 1986; Welsch, 1987; Castagnetta et al, 1992; Fishman et al, 1995; Telang, 1996) . The experiments designed in the present study have used the immortalized, non-tumorigenic MMEC and the tumorigenic myc-transfected MMEC/myc3 cells to understand the relationship between oestrogen metabolic pathways and myc-mediated tumorigenic transformation better.
The MMEC/myc3 cell line exhibits enhanced expression of the cellular markers for transformation, namely aberrant hyperproliferation in vitro before tumorigenicity in vivo. We have observed previously that (1) non-cancerous mammary tissue exhibits increased C 16x-hydroxylation of E2 to diverse carcinogenic agents British Journal of Cancer (1998) 77(10), [1549] [1550] [1551] [1552] [1553] [1554] . Cancer Research Campaign 1998 Oestrogen metabolism in myc oncogene-transfected mammary epithelial cells 1553 (Telang et al, 1991 (Telang et al, , 1997 Suto et al, 1992; Fishman et al, 1995; Telang 1996) ; (2) exposure to 16ox-OHE, results in genotoxic DNA damage and aberrant proliferation in non-cancerous mammary epithelial cells ; (3) specific E, metabolites modulate proliferation in cells pretreated with chemical carcinogens or those derived from mammary carcinoma (Schneider et al, 1984; Suto et al, 1993) ; and (4) mechanistically distinct classes of chemopreventive agents inhibit aberrant proliferation and induce C2-hydroxylation of E, (Suto et al, , 1993 Telang et al, 1997) . These observations taken together support the concept that E, metabolism may represent a biochemical/endocrine marker for mammary carcinogenesis and its prevention.
Interconversion of E, and E, has been reported to be altered in the neoplastic breast tissue owing to a change in intrinsic 17p3-HSD activity (Pollow et al, 1977; Prudhomme et al, 1984; Gompel et al, 1986; Vermeulen et al, 1986; Tait et al, 1989; Poutanen et al, 1992; Pasqualini et al, 1996) , which also appears to be different according to the hormone-responsive status of cancer cells (Castagnetta et al, 1995 (Castagnetta et al, , 1996 . This evidence is also relevant for other target cells of steroids (Carruba et al, 1997 (Pollow et al, 1977; Strobl and Lippman, 1979; Tait et al, 1989; Poutanen et al, 1993) . The oestrogen receptor status is critical for the genesis and/or evolution of a transformed cell phenotype and.
as such, modulation of the receptor status may coincide with progression of hormone-dependent tumours to a hormoneindependent status (Abul-Hajj, 1979; McCormick et al, 1982; Prudhomme et al, 1984; Welsch, 1985 Welsch, , 1987 Mauvais-Jarvis et al, 1986; Siiteri et al, 1986; Ball et al, 1988; Castagnetta et al, 1995; Nguyen et al, 1995) . In this context, it is interesting to note that MMEC/mnvc3 cells that express exogenous c-m!yc also exhibit about a 60% decrease in oestrogen receptor content relative to the parental MMEC cells.
The experiments in the present study (designed to inspect the metabolic pathways subsequent to the formation of El) demonstrated clearly that the two cell lines are able to metabolize E, via the mutually exclusive C2-hydroxylation and C16ux-hydroxylation in a manner similar to that previously observed in mammary epithelial cells that are initiated with the Ras oncogene or with the chemical carcinogen DMBA Telang et al, 1991 Telang et al, , 1992 . Furthermore, HPLC analysis confirmed that the incubation of MMEC/mYc3 cells with close to a physiological E, concentration also resulted in an appreciable 16a-OHE, formation.
Consistent with the observed cellular effects of specific E, metabolites in carcinogen/oncogene-initiated or carcinoma-derived cells (Schneider et al, 1984; Suto et al, 1992 Suto et al, , 1993 Telang et al, 1992) , 16ot-OHE, and 2-OHE, were also effective in modulating growth response of c-myc oncogene-transfected cells in the present model.
Overall, MMEC/mvc3 cells exhibit strikingly enhanced proliferative activity and persistence of the transformed phenotype that appear to be associated with (I) altered equilibrium of E, to E, conversion and consequent reduction in E, production; and (2) increased ratio of C16ot/C2 hydroxylation with consequent possible overstimulation of cell proliferation induced by both increased 1 6oxOHE, level and decreased 20HE However, concerning the relationship between aberrant hyperproliferation, altered oestrogen metabolism and c-mVc-deregulated expression, it remains unclear whether this represents a result of oncogene expression/activation or is rather a consequence of phenotypic transformation of the cells.
